Immune checkpoint inhibitors: breakthroughs in cancer treatment
Over the past two decades, immunotherapies have increasingly been considered as first-line treatments for most cancers. One such treatment is immune checkpoint blockade (ICB), which has demonstrated promising results against various solid tumors in clinical trials. Monoclonal antibodies (mAbs) are c...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
China Anti-Cancer Association
2024-06-01
|
| Schriftenreihe: | Cancer Biology & Medicine |
| Schlagworte: | |
| Online-Zugang: | https://www.cancerbiomed.org/content/21/6/451 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|